Serial Number 98729787
688

Registration Progress

Application Filed
Sep 3, 2024
Under Examination
Jun 10, 2025
Approved for Publication
Apr 15, 2025
Published for Opposition
Apr 15, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Dec 10, 2025 133 days

Trademark Image

Basic Information

Serial Number
98729787
Filing Date
September 3, 2024
Published for Opposition
April 15, 2025
Drawing Code
2

Status Summary

Current Status
Active
Status Code
688
Status Date
Jun 10, 2025
Application
Pending
Classes
005

Rights Holder

Fennec Pharmaceuticals, Inc.

03
Address
68 TW Alexander Drive
Research Triangle Park, NC 27709

Ownership History

Fennec Pharmaceuticals, Inc.

Original Applicant
03
Research Triangle Park, NC

Fennec Pharmaceuticals, Inc.

Owner at Publication
03
Research Triangle Park, NC

Legal Representation

Attorney
Joseph E. Washington

USPTO Deadlines

Next Deadline
133 days remaining
NOA E-Mailed - SOU Required
Due Date
December 10, 2025
Extension Available
Until June 10, 2026

Application History

12 events
Date Code Type Description Documents
Jun 10, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 15, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 15, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 9, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 17, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 17, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 17, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 17, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Mar 17, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 14, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 13, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 3, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, sodium thiosulfate used for the prevention of ototoxicity from cisplatin in pediatric patients

Additional Information

Design Mark
The mark consists of 10 columns comprised of varying amounts of circles per column. From left to right, the first through third columns are red, the fourth through sixth columns are magenta, the seventh column is purple, the eight column is dark purple, the ninth column is light purple, and the tenth column is blue.
Color Claim
The color(s) red, magenta, purple, dark purple, light purple, and blue is/are claimed as a feature of the mark.

Classification

International Classes
005